z-logo
open-access-imgOpen Access
Heavy chain CDR3 optimization of a germline encoded recombinant antibody fragment predisposed to bind the U1A protein
Author(s) -
Ruud MT de Wildt,
R. Ruytenbeek,
W J van Venrooij,
Rene Hoet
Publication year - 1997
Publication title -
protein engineering design and selection
Language(s) - English
Resource type - Journals
eISSN - 1741-0134
pISSN - 1741-0126
DOI - 10.1093/protein/10.7.835
Subject(s) - complementarity determining region , recombinant dna , biology , antibody , microbiology and biotechnology , genetics , gene , immunoglobulin light chain , chemistry
Previously, we described a DP-65 encoded heavy chain variable (VH) gene restriction in anti-U1A antibodies. The U1A protein (a component of the U1 ribonucleoprotein particle) is an important autoantigenic target in certain systemic lupus erythematosus (SLE) patients. Here we examined the effect of randomizing amino acids in the heavy chain complementarity determining region 3 (CDR3) of this germline encoded recombinant antibody fragment on binding to the U1A protein. A phage display library was constructed using the DP-65 VH domain with four randomized CDR3 residues and our results showed that a high frequency (10%) of the randomized mutants in the unselected library were able to bind the U1A protein. This corroborates our previous finding that this VH domain provides an appropriate structure for U1A binding, although the nature of the CDR3 residues appears crucial in determining whether or not this VH domain binds U1A. After two rounds of selection U1A binders show a consensus sequence in their randomized CDR3 residues i.e. S(K,R,S)XG, in which X is an uncharged residue. This consensus is partially present in an antibody which was derived from an SLE patient indicating that this consensus, to some extent, is also followed in vivo. Clones which match the consensus sequence obtained up to 25-fold higher affinities compared with the original clones, illustrating the importance of the VH CDR3 residues in determining the affinity of these antibodies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom